Cargando…

Idiopathic Intracranial Hypertension Associated with SARS-CoV-2 B.1.1.7 Variant of Concern

Detalles Bibliográficos
Autores principales:	Khalid, Muhammad Faran, Micieli, Jonathan A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314070/ https://www.ncbi.nlm.nih.gov/pubmed/34121637 http://dx.doi.org/10.1017/cjn.2021.129

Ejemplares similares

First Detection of SARS-CoV-2 B.1.1.7 Variant of Concern in an Asymptomatic Dog in Spain
por: Barroso-Arévalo, Sandra, et al.
Publicado: (2021)

Observations of SARS-CoV-2 variant of concern B.1.1.7 at the UK's largest hospital trust
por: Garvey, Mark I., et al.
Publicado: (2021)

Resolution of Fulminant Idiopathic Intracranial Hypertension Treated with Acetazolamide
por: Srivastava, Ojas, et al.
Publicado: (2022)

Vitreous Hemorrhage as the Presenting Sign of Idiopathic Intracranial Hypertension
por: Vosoughi, Amir R., et al.
Publicado: (2022)

Household clustering of SARS-CoV-2 variant of concern B.1.1.7 (VOC-202012–01) in England
por: Chudasama, Dimple Y., et al.
Publicado: (2021)

Subtle differences in the pathogenicity of SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in rhesus macaques
por: Munster, Vincent J., et al.
Publicado: (2021)

Three-Layered Optic Disc Hemorrhages in Idiopathic Intracranial Hypertension
por: Sverdlichenko, Irina, et al.
Publicado: (2021)

SARS-CoV-2 Variant of Concern B.1.1.7: Diagnostic Sensitivity of Three Antigen-Detecting Rapid Tests
por: Lindner, Andreas K., et al.
Publicado: (2022)

Subtle differences in the pathogenicity of SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in rhesus macaques
por: Munster, Vincent J., et al.
Publicado: (2021)

Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February
por: Grint, Daniel J, et al.
Publicado: (2021)

Replication Kinetics of B.1.351 and B.1.1.7 SARS-CoV-2 Variants of Concern Including Assessment of a B.1.1.7 Mutant Carrying a Defective ORF7a Gene
por: Pyke, Alyssa T., et al.
Publicado: (2021)

First detection of SARS-CoV-2 variant B.1.1.7 in Senegal
por: Padane, A., et al.
Publicado: (2021)

Quantification of the spread of SARS-CoV-2 variant B.1.1.7 in Switzerland
por: Chen, Chaoran, et al.
Publicado: (2021)

Tracking of SARS-CoV-2 Alpha variant (B.1.1.7) in Palestine
por: Nasereddin, Abedelmajeed, et al.
Publicado: (2022)

Influence of age on the spread of SARS-CoV-2 variant B.1.1.7
por: Dimeglio, Chloé, et al.
Publicado: (2021)

Anterior ischemic optic neuropathy in a patient with papilledema from idiopathic intracranial hypertension
por: Ma, Jingyi, et al.
Publicado: (2020)

Probable vertical transmission of Alpha variant of concern (B.1.1.7) with evidence of SARS-CoV-2 infection in the syncytiotrophoblast, a case report
por: Bullock, Hannah A., et al.
Publicado: (2023)

Impact of SARS-CoV-2 Alpha variant (B.1.1.7) on prisons, England
por: Vusirikala, Amoolya, et al.
Publicado: (2022)

Proliferation of SARS-CoV-2 B.1.1.7 Variant in Pakistan-A Short Surveillance Account
por: Umair, Massab, et al.
Publicado: (2021)

SARS-CoV-2 infection in 3,241 School working staffs: Impact of SARS CoV-2 variants of concern [Wild, B.1.1.7 and Omicron]
por: Alishaq, Moza, et al.
Publicado: (2023)

Comparison of the Performance of the PanBio COVID-19 Antigen Test in SARS-CoV-2 B.1.1.7 (Alpha) Variants versus non-B.1.1.7 Variants
por: van Ogtrop, M. L., et al.
Publicado: (2021)

Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7
por: Wang, Pengfei, et al.
Publicado: (2021)

Increased aerosol transmission for B.1.1.7 (alpha variant) over lineage A variant of SARS-CoV-2
por: Port, Julia, et al.
Publicado: (2021)

Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States
por: Alpert, Tara, et al.
Publicado: (2021)

Live attenuated virus vaccine protects against SARS-CoV-2 variants of concern B.1.1.7 (Alpha) and B.1.351 (Beta)
por: Trimpert, Jakob, et al.
Publicado: (2021)

Increased aerosol transmission for B.1.1.7 (alpha variant) over lineage A variant of SARS-CoV-2
por: Port, Julia R., et al.
Publicado: (2021)

Emergence of B.1.1.318 SARS-CoV-2 viral lineage and high incidence of alpha B.1.1.7 variant of concern in the Republic of Gabon
por: Manouana, Gédéon Prince, et al.
Publicado: (2022)

Effect of the new SARS-CoV-2 variant B.1.1.7 on children and young people
por: Brookman, Sarah, et al.
Publicado: (2021)

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
por: Supasa, Piyada, et al.
Publicado: (2021)

The first familial cluster of the B.1.1.7 variant of SARS-CoV-2 in the northeast of Italy
por: Lo Menzo, Sara, et al.
Publicado: (2021)

Monitoring differences between the SARS-CoV-2 B.1.1.7 variant and other lineages
por: Jewell, Britta L
Publicado: (2021)

Potential transmission chains of variant B.1.1.7 and co-mutations of SARS-CoV-2
por: Zhang, Jingsong, et al.
Publicado: (2021)

SARS-CoV-2 B.1.1.7 Variant Infection in Malayan Tigers, Virginia, USA
por: Mitchell, Patrick K., et al.
Publicado: (2021)

Introduction and transmission of SARS-CoV-2 lineage B.1.1.7, Alpha variant, in Denmark
por: Michaelsen, Thomas Y., et al.
Publicado: (2022)

The Alpha Variant (B.1.1.7) of SARS-CoV-2 Failed to Become Dominant in Mexico
por: Zárate, Selene, et al.
Publicado: (2022)

The SARS-CoV-2 B.1.1.7 variant and increased clinical severity—the jury is out
por: Giles, Benjamin, et al.
Publicado: (2021)

Genome sequencing of SARS-CoV-2 reveals the prevalence of variant B 1.1.7 in Egypt
por: Seadawy, Mohamed G., et al.
Publicado: (2022)

Precision Response to the Rise of the SARS-CoV-2 B.1.1.7 Variant of Concern by Combining Novel PCR Assays and Genome Sequencing for Rapid Variant Detection and Surveillance
por: Zelyas, Nathan, et al.
Publicado: (2021)

SARS-CoV-2 B.1.1.7 UK Variant of Concern Lineage-Related Perceptions, COVID-19 Vaccine Acceptance and Travel Worry Among Healthcare Workers
por: Temsah, Mohamad-Hani, et al.
Publicado: (2021)

Early introductions and community transmission of SARS-CoV-2 variant B.1.1.7 in the United States
por: Alpert, Tara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rs8qqpisf4ohj7kv9f1kltotsv